Education

Filtering by: Education

From Idea to Start-up
Feb
12
5:30 pm17:30

From Idea to Start-up

  • New Biochemistry Building, Main Seminar Room (map)
  • Google Calendar ICS

If you have an idea but you don’t know where to start or if you are interested in entrepreneurship, this is a must-attend event for you!

In this event, participants will have the opportunity to engage in a science innovation workshop.

Speakers will present their experiences as either successful science entrepreneurs or investors, giving valuable tips on how to make the transition from a good idea to building a start-up and securing investment. At the end, participants will have the chance to take part in a “hands-on” activity and interact with our experienced speakers. Limited spots available.

There will be a networking & drinks reception after the event!

As always, this event is free and everyone is welcome!

View Event →
Academic Breakout: Alternative careers in biotech
Jan
25
7:00 pm19:00

Academic Breakout: Alternative careers in biotech

During this event we will have representatives from the biotech industry to discuss a range of career paths within the field itself. As early career academic scientists, we typically are not aware of the many career opportunities that are available to us within industry. Therefore, this will be an informative career talk with our event speakers highlighting traditional as well as alternative career paths which early career scientists should consider as they transition out of academia.

If you would like to inform yourself about how to do the transition out of academia, don't miss the opportunity and join our discussion with expert speakers in the field. Learn how to start a career outside of academia and thrive in industry.

Our speakers are: 
- José Airas, Director of Inhouse consulting at Merck
- Karin Messer-Recruiting Manager at Sanofi-Aventis
- Jens Atzrodt Head Hub Management Office, Sanofi German R&D Hub, Frankfurt

 

There will be an opportunity for networking after the event. As always, this event is free and everyone is welcome!

 
View Event →
SIUFrankfurt: The Human Side of AI: The Role of Artificial Intelligence In Society
Nov
20
7:00 pm19:00

SIUFrankfurt: The Human Side of AI: The Role of Artificial Intelligence In Society

In our SIU Translations event series, we discuss how scientific improvements can be translated into real-life solutions. At this event we will discuss how artificial Intelligence is transforming our society, what the current and near future applications of AI are and how humans can use these technologies more ethically and intelligently.

GUEST SPEAKERS: PROF. ROBERTO ZICARI, PROF. GREGORY WHEELER, PROF. DANKO NIKOLIC

CASINO CONFERENCE ROOM 1.811, CASINO BUILDING, CAMPUS WESTEND, NORBERT-WOLLHEIM-PLATZ 1 (7:00 PM TO 10:00 PM)

Prof. Roberto Zicari, founder of the Frankfurt Big Data Lab (Goethe University Frankfurt) - will give a talk titled: "Big Data, Data Science and The Great A.I. Awakening — Civil and Societal implications". He will address the ethical and societal implications of using Big Data and AI technologies for high stakes decision making, such as medical diagnosis, loan approvals, hiring and crime prevention.

Prof. Gregory wheeler, Professor of Theoretical Philosophy and Computer Science at the Frankfurt School of Finance and Management, will address the interdisciplinary nature of AI and how the basic research from different fields is giving rise to the advances in AI research. Additionally, he will address how this research can be utilized in service of more people and improve our life quality. 

Prof. Danko Nikolic, researcher at the MPI for Brain research and FIAS research fellow, will be giving examples from his own research and more specifically, how he is applying concepts from human cognitive development research to AI development. 

View Event →
SIUKatowice: The Future Careers of Medical Students and Resident Physicians
Nov
17
5:30 pm17:30

SIUKatowice: The Future Careers of Medical Students and Resident Physicians

The role of the physician is constantly evolving just as healthcare systems are continuously being amended. Physicians, making up the bulk of the primary health work force, require an equally strong healthcare system that cares not only for its patients, but for its employees as well. With ongoing changes in political, social and economical landscapes, the healthcare system needs reactionary changes that creates a healthy relationship between the patient, the doctor and the governing authority, allowing for the doctor-patient and government-doctor relationship to be equally satisfied and strong. The establishment of this relationship is the cornerstone for future of Polish medical students and resident physicians. 

We would like to invite you to an educational discussion of this very relationship with our panelists consisting of Polish and foreign medical students, government health officials and resident physicians, who will shed light onto the current hunger strikes concerning healthcare in Poland and other controversial topics whilst standing true to the Hippocratic Oath!

There will be a networking session & drinks reception after the event!

A3 LECTURE HALL, MEDICAL UNIVERSITY OF SILESIA (5:30 PM - 7:30 PM)

View Event →
How A Bad Commercial Strategy Can Kill A Great Technology
Nov
16
6:30 pm18:30

How A Bad Commercial Strategy Can Kill A Great Technology

  • Lecture Theatre 1, London Business School (map)
  • Google Calendar ICS

As a researcher, what does it mean to develop a commercial strategy and if the underlying technology is great (so compelling that it sells itself) do you really need one? We will discuss the ‘sad’ case of a researcher who put his all into commercialising a new technology but who - after burning through his cash had sales that ‘approximated to zero’. We are going to ask whether it was the technology, the market need or his commercial strategy that was to blame. And what he should do next. Along the way we will decompose the elements of a commercial strategy so that you can apply the same framework to yours.

Participants will be emailed some short pre-workshop material to read over 1 week in advance. Please look over this to ensure you are ready to get the most from the workshop.

GUEST SPEAKER: DR JEFF SKINNER

LECTURE THEATRE 1, LONDON BUSINESS SCHOOL, NW1 4SA (6:30 PM TO 9:30 PM)

Jeff Skinner is Director of the Institute of Innovation and Entrepreneurship at London Business School. He actively mentors, encourages and teaches dozens of aspiring entrepreneur MBA students each year. The rest of his time is spent elsewhere in Europe working with scientists who yearn to commercialise their technology and training the technology transfer managers who guide them. Prior to this he was Commercial Director at UCL where he built and ran the spin-out, licensing, R&D collaboration and consultancy units. He holds a PhD from UCL and a MBA from LBS.

View Event →
Labstep: Building A Start-up To Help The Research Community
Nov
13
1:00 pm13:00

Labstep: Building A Start-up To Help The Research Community

In this talk, CEO of Labstep Jake Schofield will detail his entrepreneurial journey and how he expanded his platform to where it is today. This will be a great opportunity to learn how to formulate and actualize an idea that meets a need that is currently unsatisfied in the target demographic’s space. Jake will also speak to company fundraising and how he built his team using the resources available within Oxford.

Labstep Ltd is an online tool used by more than 350 universities worldwide that lets you create a personal or shared timeline with your lab group to track your experimental progress in the lab. You can write updates of your experiments and attach results to keep an accurate record of your work. Labstep allows you to create a library of your experimental methods onto a protocol playlist. You can easily run any of your protocols and make edits to them whenever you make a slight modification to increase reproducibility.

As always, this event is free and everyone is welcome!

View Event →
The Rise of Artificial Intelligence
Oct
12
5:30 pm17:30

The Rise of Artificial Intelligence

Programme
17:30 – 17:45 Introduction to Science Innovation Union (SIU)
17:45 – 18:00 Speaker 1: Dr. Krysztof Jakubczak, An experienced R&D engineer and optoelectronics domain manager
18:00 – 18:15 Speaker 2: Dr. Zbiniew Nawrat, Theoretical physicist, director of Institute of Heart Prostheses
18:15 – 18:30 Speaker 3: Mr. Piotr Krajewski, CEO and owner of Cancer Center AI helping to improve cancer diagnoses
18:30 – 18:45 Speaker 4: Dr. Oskar Kiwic, CEO and startup owner of CardioCube, a medical artificial intelligence company designed to optimize patients therapy treatments
18:45 – 19:15 Q&A and panel discussion

19:15 onwards there will be drinks and small bites in the foyer outside the A3 Conference Hall

GUEST SPEAKERS: DR KRYSZTOF JAKUBCZAK, DR ZBINIEW NAWRAT, PIOTR KRAJEWSKI, DR OSKAR KIWIC

A3 LECTURE HALL, MEDICAL UNIVERSITY OF SILESIA (5:30 PM - 9:00 PM)
 

Dr Jakubczak graduated from the Institute of Optoelectronics of the Military University of Technology in Warsaw (MSc) and Czech Technical University in Prague (PhD).  He is an experienced R&D engineer and manager in the optoelectronics domain. He worked as a Deputy Project Manager at new R&D HiLASE Center in Czech Republic on innovative laser technologies for industry and as an Operations Director for the National Center for Research and Development. He cooperates with LaserLab Europe, MIT Enterprise Forum Poland, Polish Standardization Committee, investors and technological innovators.

Dr. Nawrat is a theoretical physicist, who devoted his professional life to advance the field of medical robotics and artificial organs. He pioneered research in artificial organs domain, especially heart valve prostheses and blood pumps (POLVAD) and created the Robin Heart surgical robot - first Polish and European telemanipulator for heart surgery. He developed the application of computer simulation in surgical planning and founded the International Society for Medical Robotics. He works in Medical University of Silesia Department of Cardiosurgery and Transplantology, Foundation of Cardiac Surgery Development as a director of Institute of Heart Prostheses and is a member of Biomechanics and Biomaterials sections of Polish Academy of Sciences.

Mr. Krajewski has his masters in Computer Science and Electronics from the Technical University of Wroclaw. He has shown that he can turn dreams into concrete projects with his personal story prompting him to set up CancerCenter.AI, which aims to improve the diagnosis of cancer. He does his own business (Stermedia.eu), and is involved in projects in the field of science and business. 

Dr. Kiwic is a young inventor and future doctor, who believes in the power of technology and medicine. In addition to his medical degree, he also has an additional qualification in neuroscience in which he obtained from the University of Glasgow. For the last couple of years he has been developing products in healthcare. Now he runs CardioCube, a game-changing medical artificial intelligence company helping cardiac patients

View Event →
Frankfurt Session 5: Brain on, dude! Working at the interface of science, communication and media.
Jun
7
7:00 pm19:00

Frankfurt Session 5: Brain on, dude! Working at the interface of science, communication and media.

Welcome to SIUConversations! In our speaker series we invite renowned experts from various fields of industry and academia, who will share insides into their personal career trajectories. Our aim is to inform students and early researchers (PhD, PostDocs) of diverse career possibilities through the examples of our speakers. After each talk, the audience will have the chance to get to know the speakers and organizers in an informal wine and cheese setting.

Our speaker for this event will be Dr. Henning Beck.
Henning Beck started his doctorate at the Hertie Institute for Clinical Brain Research in Tübingen in 2008 and finished it at the Institute of Physiological Chemistry at the University of Ulm eventually receiving his PhD from the Graduate School of Cellular and Molecular Neuroscience in Tübingen. Not long after finishing his doctorate, Dr. Beck also completed his international Diploma in Project Management at the University of California Berkeley.

Since 2011, he has been traveling Germany as a "Science Slammer" eventually going on to win the German Nationals for his lecture on “Speed up your mind”. Dr. Beck continues to give lectures, workshops, and performances in which he breaks down the complicated issues of neuroscience in an understandable and entertaining manner to audiences around Germany. Dr. Beck is a regular contributor to GEO-Magazine and Wirtschaftswoche where he comments on the newest trends in brain science.

Additionally, he has authored multiple books in which he explains complicated issues in an understandable and engaging way. In his latest book, published earlier this year, "Irren ist nützlich. Warum die Schwächen des Gehirns unsere Stärken sind", he discusses why we are so often distracted, find it difficult to concentrate, or easily forget things. More importantly, he tells us why these supposed deficiencies may not be such a problem at all. Dr. Beck has been able to artfully explain complicated science to a wider audience in his TEDxTalk, contributions to Wired-magazine or SWR-television.

To find out more about Dr. Beck's latest book, as well as what is like to transition from the world of academia to a successful speaker and author join us at the SIU seminar series.

View Event →
Frankfurt Session 4: Take the next step: How to thrive outside of academia with your scientific background
May
31
7:00 pm19:00

Frankfurt Session 4: Take the next step: How to thrive outside of academia with your scientific background

Welcome to SIUConversations! In our speaker series we invite renowned experts from various fields of industry and academia, who will share insides into their personal career trajectories. Our aim is to inform students and early researchers (PhD, PostDocs) of diverse career possibilities through the examples of our speakers. After each talk, the audience will have the chance to get to know the speakers and organizers in an informal wine and cheese setting.

Our speaker for this event will be Dr. Patrick Britz.
Are you considering starting a company or working for an existing company with the skills you gained during your PhD?

If yes, come and join this exciting session to listen to Patrick Britz who turned the company Brain Vision into a leading distributor for neuroimaging equipment and a reliable partner for many research labs around the world.

In this talk he will share his own success path with us by giving valuable information on:

-        How to prepare yourself for a career outside of academia

-        What to pay attention to when you are applying for a job

-        How to use your scientific knowledge to create a company

-        What are the highs, lows and mistakes of creating a company in the research market

Patrick is the CEO & President of Brain Vision LLC and the Marketing Director at Brain Products GmbH. He also holds a PhD degree in Biopsychology. During his PhD, he started working for Brain Vision as a scientific consultant and not long afterwards was promoted to President of Brain Vision thanks to his problem-solving skills and commitment to providing solutions to Neuroscientists. 

View Event →
Frankfurt Session 3: How I plan to revolutionise artificial intelligence by capitalising on decades of scientific research
May
17
7:00 pm19:00

Frankfurt Session 3: How I plan to revolutionise artificial intelligence by capitalising on decades of scientific research

You like doing research, but how about applications? Is it possible to do both at the same time? In this talk you can learn from an expert who achieved this already. Come and join us to learn from Prof. Christoph von der Malsburg.

GUEST SPEAKER: DR. CHRISTOPH VON DER MALSBURG

GOETHE UNIVERSITY | PEG 1.G192, THEODOR-W. ADORNO-PLATZ 6 (7:00 PM TO 9:00 PM)

Dr. Christoph von der Malsburg is Senior Fellow at the Frankfurt Institute for Advanced Studies (FIAS) since 2007. He received his PhD in physics from the University of Heidelberg, Germany, and CERN in Geneva. Subsequently, he joined the section of Neurobiology of the Max-Planck-Institute for Biophysical Chemistry in Göttingen, before becoming Professor of Computer Science, Neuroscience, Physics and Psychology at the University of Southern California in Los Angeles.

Eventually, Professor von der Malsburg returned to Germany as a Professor of Systems Biophysics at the Ruhr University Bochum where he founded the Institut für Neuroinformatik together with Werner von Seelen. In 1997, he co-founded the company ZN Vision, which develops face recognition technology now under the name L 1 Identity Solutions AG in Bochum, and the company Eyematic, the core of which is now part of Google.

Among a number of prestigious awards (IEEE Pioneer Award 1994, Beckurts Foundation Award 1998, Hebb Award 2003), Professor von der Malsburg received the Körber European Science Prize in 2000 for his innovative contributions to the perception of shape in technology with insights from nature. He is a renowned pioneer in his field, studying the processes of self-organisation in the visual system and the creator of the Dynamic Link Architecture. He recently founded the company Platonite.

View Event →
Oxford Session 4: Meet the CEO
May
15
5:30 pm17:30

Oxford Session 4: Meet the CEO

Come join this exciting session to meet three Oxford alumni and early career researchers who turned their brilliant concepts into reality. These entrepreneurs will each share their stories about how they developed their ideas and turned them into successful businesses. After a series of short flash presentations from each CEO, the session will move on to a panel discussion, where you can ask your own specific questions to the panellists. Come and find out how to progress your career from a student to CEO.

GUEST SPEAKERS: RIHAM SATTI, EKATERINA DAMER AND JOHN STUART

NEW BIOCHEMISTRY BUILDING, SOUTH PARKS RD, OX1 3QU - (5:30PM TO 7.30PM)

Riham Satti CEO of MeVitae, an AI decision-making platform in the human capital sector, is amongst the top disruptive game changers in Thames Valley and top tech business leaders. She works with some of the most innovative tech companies around the world.

Ekaterina Damer is the CEO of Prolific. In her own words: "Prolific is the most fun, fair, and efficient participant recruitment platform for scientists and startups. We've bootstrapped our startup to £1M in sales with zero marketing spend and without having raised investment (yet)". 

John Stuart is the founder and CEO of Bounts Limited. Bounts is a digital health platform that aims to motivate people to keep committed to a healthy life. After 6 years and £1.5m investment, John has been through all the highs, lows and mistakes of creating a company from scratch.

View Event →
Frankfurt Session 2: ‚We‘: The social identity approach to effective leadership
May
10
7:00 pm19:00

Frankfurt Session 2: ‚We‘: The social identity approach to effective leadership

Want to learn how to be a leader and how to manage people while working in groups? These are the skills you should have as a researcher and we have the best tips for you from an expert in the field! Join us and learn from Prof. Rolf Van Dick.
During his talk in the SIU seminar series Prof Van Dick hopes to present insights about identity and leadership as well as his own experiences working with companies.

GUEST SPEAKER: PROFESSOR ROLF VAN DICK

GOETHE UNIVERSITY | PEG 1.G192, THEODOR-W. ADORNO-PLATZ 6 (7:00 PM TO 9:00 PM)

Professor van Dick started his psychology career at Philipps-University Marburg where he earned his PhD under the supervision of Ulrich Wagner. Following his time in Marburg, Professor van Dick became first a senior lecturer and eventually a full professor at Aston University in Birmingham, England.

In 2006, he returned to Germany as the chair for Social Psychology at the Goethe-University. Additionally, he has been a visiting professor at several universities across the world and as of 2016 he holds and additional professorship at the Work Research Institute in Oslo, Norway. Rolf van Dick is co-founder and Scientific Director of the Center for Leadership and Behavior in Organizations (CLBO) at Goethe University.

He is an internationally renowned expert for inter- and intra- group processes, identity, diversity, and leadership.He has also worked on such topics as stress and job satisfaction. Professor van Dick, is not only a profound researcher, but also well-loved among the Frankfurt psychology students as a two-time winner of the YAVIS award for outstanding teaching. 

View Event →
Cambridge Session 4: Meet the Founder, Pitch Perfect
Apr
28
10:30 pm22:30

Cambridge Session 4: Meet the Founder, Pitch Perfect

Come listen to pitch-structured presentations by successful biomedical start-ups based in Cambridge. These companies are excited to share how they managed to launch a business from a scientific idea and will discuss their background, current project and future directions.

GUEST SPEAKERS: SIMON LAMBDEN, SU METCALFE, ATTILA CSORDAS, PORTIA ASLI 

DEPARTMENT OF ENGINEERING, UNIVERSITY OF CAMBRIDGE (7-9 PM)

Dr Simon Lambden is part of the academic intensive care team of the University. He will present his experience in launching and securing funding for his new start-up based on a new treatment for sepsis, a life threatening condition that arises when the body’s response to infection causes injury to its own tissues. He will address the issue of convincing private sector funders to invest in a novel idea.

Su Metcalfe is the founder and CSO of LifNano Therapeutics. LIFNanoRx is a nano-bio-med company focused on treatment of Multiple Sclerosis (MS), an auto-immune inflammatory disease of the central nervous system. Using a critical stem cell factor with unique biological properties alongside nanoparticle technology, they present a new approach to the treatment of MS.

Attila Csordas is the founder AgeCurve, a startup with a vision to provide deep molecular age profiles for every grown-up. They believe that the complexity of ageing can be captured reliably by detecting molecular patterns and analysing big chunks of people’s proteome from saliva, to learn and to assess lifestyle interventions.

Portia Asli is the chief commercial officer of Vocalens, a Cambridge University spin-out startup co-founded by Cambridge engineers and MBAs, developing smart wearable assistive technology for people with visual impairment.

View Event →
Frankfurt Session 1: Academia's bittersweet box of chocolates: (Tr)eat with caution!
Apr
19
7:00 pm19:00

Frankfurt Session 1: Academia's bittersweet box of chocolates: (Tr)eat with caution!

Do you want to hear some insider tips on how to become a professor at a young age? Come and join our first SIU session in Frankfurt and get some advice from Prof Melissa Vo. 

Professor Vo will share with SIU members how she managed to become a successful scientist, what she sees as difficulties in that carrier choice and how to handle them, while maintaining the ever illusive life-work balance.

GUEST SPEAKER: PROFESSOR MELISSA VO

GOETHE UNIVERSITY | PEG 1.G192, THEODOR-W. ADORNO-PLATZ 6 (7:00 PM TO 9:00 PM)

Melissa Vo is the head of the Scene Grammar Lab at the Goethe University. Before becoming a professor in Frankfurt, she earned her PhD in Psychology from LMU in her home town of Munich. After her PhD she went on to work at the University of Edinburgh and Harvard University. During her whole carrier she has been maintaining a keen interest in visual cognition and particularly scene perception.

After her time at Harvard University, Professor Vo received the coveted Emmy Noether Grant from the German Research Foundation. In 2014 she returned to Germany as a professor in Cognitive Psychology at Goethe University Frankfurt as the youngest professor in the department. In her first year in Frankfurt she was awarded the YAVIS award for outstanding teaching. Additionally, she is an active member of SciMento – a mentoring program targeted at talented female PhD students and postdocs from 5 universities in Hessen.

View Event →
London Session 4: Turning scientific research into a business
Dec
1
6:00 pm18:00

London Session 4: Turning scientific research into a business

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/1632034013488876/
Session 2: https://www.facebook.com/events/549654898557804/
Session 3: https://www.facebook.com/events/1653754461601574/

Session 4: In the final session of the series we explore the process of creating translational start-ups and technologies. Attendees will discover the life-cycle of a start-up and the hurdles that must be overcome. Additionally, risk-assessment and idea development will be explored.

Speaker: Matthew Durdy
Matthew joined the Cell and Gene Therapy Catapult in 2012, from the novel therapeutics company Aqix, where he was Chief Executive. He has broad experience in the biotechnology industry leading SMEs, raising finance and commercialising diagnostics, medical devices, and therapeutics for regulated use in the EU. He was also an expert advisor to the World Health Organisation on medical innovation strategy. Matthew was also a Director at the venture capital firm CDC, where he was responsible for due diligence and new investment in their $3.5bn international portfolio.

View Event →
Oxford Session 4: Fates of successfully translated technologies
Nov
29
7:00 pm19:00

Oxford Session 4: Fates of successfully translated technologies

  • Saïd Business School, University of Oxford (map)
  • Google Calendar ICS

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/636423359851397/
Session 2: https://www.facebook.com/events/1282123598478793/
Session 3: https://www.facebook.com/events/103430890126308/

Session 4: Fates of successfully translated technologies
In the final session of the series we explore the fates of successful start-ups and technologies. When is licencing your technology to an already established company in your sector a better route forward and when is the time right to float. Why does there seem to be a tendency for British firms in particular to be acquired by larger foreign organisations? When can this be the best outcome? We evaluate which are the most appropriate way to get your technology into the hands of those who would use it, and look at case studies of successful start-ups who have chosen each of these routes.
.
Speaker: Brian Graves
Brian joined Imperial Innovations in 2001 as head of the Engineering Technology Transfer team having previously gained over 20 years' experience in business development, product development and marketing in the engineering industry with John Crane Limited, a division of Smiths Group plc

View Event →
London Session 3: Gaining the support of large organisations
Nov
21
6:00 pm18:00

London Session 3: Gaining the support of large organisations

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/1632034013488876/
Session 2: https://www.facebook.com/events/549654898557804/
Session 4: https://www.facebook.com/events/104791129993224/

Session 3: Findings through scientific research can be grand. In an academic environment, these high impact findings may not necessarily reach the public, even though it may directly affect this audience. Collaborating with large organisations, biotech companies, and the government may jump this hurdle. In this session, attendes will learn how to pitch outreach ideas to these organisations, and how to highlight benefits to that organisation in participating in translating scientific research that may not necessarily be a product of their institution. 

Speaker: Tijana Duric. 
GSK is working with many partners to eliminate and control some of the neglected tropical diseases. Tijana has been with GSK for 7 years, enetering as a supply chain manager. Her role now is tailored towards private-public partnerships and global health. Tijana looks after the supply planning for albendazole, a treatment for a variety of parasitic worm infections.

View Event →
Oxford Session 3: Quelling fears; runways, risks and expectations
Nov
15
7:00 pm19:00

Oxford Session 3: Quelling fears; runways, risks and expectations

  • Saïd Business School, University of Oxford (map)
  • Google Calendar ICS

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/636423359851397/
Session 2: https://www.facebook.com/events/1282123598478793/
Session 4: https://www.facebook.com/events/359868271018146/

Session 3: Quelling fears; runways, risks and expectations.
Translational scientists at the very beginning of their careers face a choice, do they elect to stay in academia and to some extent minimize their involvement in the running of their start-up, or if presented with the opportunity, should they take on the start-up as a full time occupation. The prospect of translating research into commercially useful products has its risks, indeed the statistics on success rates of start-ups are superficially quite alarming, but is taking on a postdoctoral position really much less risky? After all the proportion of PhD students that end up in a permanent academic position is also very low. Here we will explore the different areas of risk along the trajectory of a new start-up, from securing protected IP, to gathering funding, developing a technology to choosing the right people. If a young scientist decides to take on an idea and decides to develop the start up as their full time position how does one set appropriate targets by which to judge progress and succes. If the project ultimately ends in failure from a business point of view, where does that leave the founder? What’s next? What are the benefits of being fully involved in your start up, whether it succeeds or fails, from both a learning, enjoyment and scientific point of view?
.

Speaker: Steven Zimmer
Trained as a Biochemist and Molecular Biologist, Steven has had a long career as an analyst, investment banker and portfolio manager on Wall Street and in the City of London. He was a co-founder, Protein Sciences Inc., Steribottle Ltd and Tissuomics and has been an investor and advisor to many ventures and companies over the past 30 years. His latest position was as an advisor on Business and Strategic Development at e-Therapeutics plc, an AIM-listed network pharmacology-based drug discovery company based in Newcastle, UK.

View Event →
London Session 2: Developing strategies for public engagement
Nov
3
6:00 pm18:00

London Session 2: Developing strategies for public engagement

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/1632034013488876/
Session 3: https://www.facebook.com/events/1653754461601574/
Session 4: https://www.facebook.com/events/104791129993224/

Session 2: Developing strategies for public engagement.
Sharing great science with an audience can be a difficult task when raised in the lab environment and trained to publish in scientific journals. Where can scientific outreach be taken? What is the best way to convey research to a non-scientific audience? How is a public outreach event planned and organised? What language needs to be used for the proposed science to be understood by a wide audience and how can the importance of this science be made clear? In this session speakers will demonstrate strategic plans for creating public outreach events. Attendees will learn how to build an image of their work that will be clear and engaging for a wide audience. 

Speaker: Steven Zimmer, BSc(Hon), MSc.-Founder, Director and CEO - MitoDys Therapeutics

Steven trained as a Biochemist and Molecular Biologist, Steven has had a long career as an analyst, investment banker and portfolio manager on Wall Street and in the City of London. He was a co-founder, Protein Sciences Inc., Steribottle Ltd and Tissuomics and has been an investor and advisor to many ventures and companies over the past 30 years. His latest position was as an advisor on Business and Strategic Development at e-Therapeutics plc, an AIM-listed network pharmacology-based drug discovery company based in Newcastle, UK.

View Event →
Oxford Session 2: Company structure, what is your role?
Nov
1
7:00 pm19:00

Oxford Session 2: Company structure, what is your role?

  • Saïd Business School, University of Oxford (map)
  • Google Calendar ICS

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 1: https://www.facebook.com/events/636423359851397/
Session 3: https://www.facebook.com/events/103430890126308/
Session 4: https://www.facebook.com/events/359868271018146/

Session 2: Company sturcture, what is your role?
For many researchers, starting a company can be an exciting and immersive experience, however it is also one with heavy time and resource demands. As the majority of translational academic scientists will already have full time positions (either as staff of students), how can one run a company and maintain the high standard of work and dedication expected of their permanent position? Start-ups must be very dynamic and adaptable enterprises, and consequently the role of the founding scientist clearly changes dramatically over the time course of a company. Here we will look at the structure of a start-up and how this structure changes over time through the course of developing a start up from the early stages of just an idea, to an organisation gathering investment with a dedicated managerial team all the way to a profit making private or public company.

Speakers: Professor Jonathan Seville, Adrian Griffiths and Kevin Marks

Professor Seville is the Executive Dean of the Faculty of Engineering and Physical Sciences at the University of Surrey. He holds degrees in Chemical Engineering from the university of Cambridge and the University of Surrey and is a Fellow of the Institution of Chemical Engineers and a Fellow of the Royal Academy of Engineering. Professor Seville has an impressive record in the application of his science in the manufacturing of products in numerous industries, working with an extensive list of some of the largest companies in science, including Astra Zeneca, BP, Siemens and Unilever to name just a few. He also co-founded the successful spin-out company Recycling Technologies, of which he now sits on the advisory panel.

Adrian Griffiths is the current managing director of Recycling Technologies Ltd, and has extensive commercial and technical experience in many manufacturing sectors. Adrian holds a Bachelor of Engineering from Imperial college London.

Kevin Marks is the Chief Operating Officer of Warwick Ventures, Warwick universities commercialisation technology transfer office. Kevin hold a Bachelor degree in Engineering Science and an MBA from Warwick University, as well as an MPhil in electrical engineering from the University of Birmingham.

View Event →
London Session 1: Platforms for translating research
Oct
27
6:00 pm18:00

London Session 1: Platforms for translating research

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 2: https://www.facebook.com/events/549654898557804/
Session 3: https://www.facebook.com/events/1653754461601574/
Session 4: https://www.facebook.com/events/104791129993224/

Session 1: Platforms for translating research.
For many scientists, translating research means publishing their work in a journal. These publications are critical in advancing our knowledge, however, a non-scientist audience would find it difficult to interpret these findings, and may therefore be excluded from the advancements scientist are achieving, which may be directly linked to the benefit of the public! In this session, the focus will be held on finding appropriate platforms for getting research known to the public. What organised events exist for bringing ideas forward? How to portray research so that it makes sense to a non-scientist? What are the best ways for exposing science to gain the largest impact? 

Speaker: Dr Amir Gander is the lead individual for Tissue Access for Patient Benefit (TAPb), a UCL initiative to bring surplus human tissue from surgery and biobanks to researchers across UK and internationally. Amir was involved with quality management and regulations and also specialised in the development of bench scale drug fermentation techniques to large production scales at a leading pharmaceutical production plant. TAPb has established a network of researchers interested in tissue from specific disease pathways. In collaboration with the state-of-the-art biobank at the Royal Free Hospital London, they have started to supply tissue (with clinical information) to a number of research companies and have strong ties with public and private sector researchers.

View Event →
 Oxford Session 1: Opportunity recognition and construction
Oct
18
7:00 pm19:00

Oxford Session 1: Opportunity recognition and construction

  • Saïd Business School, University of Oxford (map)
  • Google Calendar ICS

The Science Innovation Union is offering a groundbreaking bio-entrepreneurship course aimed directly at the UK’s top scientists and budding entrepreneurs. The programme consists of a series of four exciting sessions lead by high profile leading academics and industry experts. Head to our website to sign up now! http://science-union.org/siu360-application

Links to other three session in the SIU360 series:
Session 2: https://www.facebook.com/events/1282123598478793/
Session 3: https://www.facebook.com/events/103430890126308/
Session 4: https://www.facebook.com/events/359868271018146/

Session 1: Opportunity recognition and construction.
For those individuals at the start of their entrepreneurial career, one of the most difficult challenges is to learn how to spot opportunities that are worth chasing. Is there a demand? Is the proposed solution appropriate and economically viable? Is the timing right? Is the technology protectable from an IP point of view? This list of questions, which is far from exhaustive, are all questions which clearly need to be addressed, however the answers are not always obvious. Attendees will acquire knowledge and skills which will aid them in their assessment of opportunities and allow them to make better decisions when considering which ideas represent realistic and compelling opportunities.

Speaker: Chas Bountra is Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. He is also a Visiting Professor in Neuroscience and Mental Health at Imperial College, London. He is an invited expert on several government and charitable research funding bodies, and an advisor for many academic, biotech and pharma drug discovery programmes.

Prior to coming back to Oxford, Chas Bountra was Vice President and Head of Biology at GlaxoSmithKline. He was involved in the identification of more than 40 clinical candidates for many gastro-intestinal, inflammatory and neuro-psychiatric diseases.

View Event →